Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Lexaria Bioscience Corp

LEXX ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: BUY

Last Close

$10.92

▼ -3.15%

Market Cap $18.04M · Vol 1.31K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$18.04M

Micro Cap

Div Yield

N/A

EPS Growth

+44.70%

YoY

RSI (14)

87.71

Momentum

Beta

0.45

vs Market

52W High

$23.25

53.05% below

52W Low

$4.38

149.20% above

Volume

1.31K

Avg 4.72K

P/B

5.76

Price-to-book

ROE

N/A

Return on equity

Free Float

96.68%

Public shares

Shariah Compliance8 STANDARDS

✗ Lexaria Bioscience Corp (LEXX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LEXX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+20.74%

+31.40%

+20.16%

+11.71%

YTD

+17.94%

-7.41%

-32.62%

-87.48%

Financials & Valuation

TTM · Annual

Total Revenue	$705.92K
Net Income	$-11,911,430.00
Revenue Growth (YoY)	-100.00%
Gross Margin	99.61%
Operating Margin	-1,683.01%
Net Profit Margin	-1,687.36%
ROE	N/A
ROA · ROIC	-182.65% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	22.44
P/B	5.76
P/FCF	N/A
EPS Growth	+44.70%
Outstanding Shares	1.65M

Technical Indicators

50-Day SMA	$8.27
200-Day SMA	$11.08
RSI (14)	87.71
Beta	0.45
52-Week High	$23.25
52-Week Low	$4.38

Volume Today	1.31K
Avg Daily Volume (30D)	4.72K
Relative Volume	0.28x
Volatility (10D)	139.45
Volatility (30D)	167.05
Free Float	96.68%

Analyst Consensus

BUY

Current Price $10.92

Mean Target $52.50

52W Low$4.38 52W High$23.25

Current

Target

$4.38 $23.25

Current Analyst target

+380.99% upside potential · 2 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SBJ1Q1

ISINUS52886N4060

CountryCanada

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 26, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co +0.88% JNJ Johnson & Johnson +1.07% ABBV Abbvie Inc +1.20% NVS Novartis AG +1.68% NOVN.S Novartis AG +0.85%

Company Profile

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery formulation and processing platform technology improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. The Company’s segment includes Intellectual Property, B2B Production, and Research and Development. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its focus is the investigation and the incorporation of its DehydraTECH drug delivery technology with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to enhance absorption and reduce adverse side effects. The Company operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 48 patents granted and many patents pending worldwide.